US Stock MarketDetailed Quotes

TCBP TC BioPharm

Watchlist
  • 1.5300
  • -0.0400-2.55%
Close Apr 26 16:00 ET
  • 1.5700
  • +0.0400+2.61%
Post 19:36 ET
4.89MMarket Cap-63P/E (TTM)

TC BioPharm Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
31.04%-10.54M
-174.01%-15.29M
-62.62%-5.58M
-67.45%-2.55M
-1.09M
49.00%-3.43M
-1.52M
-6.73M
Net income from continuing operations
-349.68%-5.91M
91.23%-1.31M
-126.00%-14.98M
-168.52%-4.52M
---7.3M
3.83%-6.63M
---1.68M
---6.89M
Operating gains losses
49.97%-7.97M
-475.26%-15.94M
224,465.20%4.25M
45,841.19%271.05K
--3.97M
-97.40%1.89K
--590
--72.69K
Depreciation and amortization
-17.75%633.01K
-24.92%769.6K
-4.66%1.03M
-6.78%250.35K
--249.31K
18.88%1.08M
--268.56K
--904.47K
Other non cash items
-89.40%717.41K
96.85%6.77M
1,081.49%3.44M
2,692.96%1.92M
--1.15M
14.80%291.03K
--68.81K
--253.51K
Change In working capital
122.96%1.54M
-2,789.09%-6.7M
-402.61%-232.08K
14.28%-410.55K
---270.81K
104.23%76.69K
---478.92K
---1.81M
-Change in receivables
316.24%676.41K
47.13%-312.8K
-134.22%-591.62K
-953.54%-447.53K
---244.18K
569.96%1.73M
--52.43K
--258.05K
-Change in prepaid assets
-3,300.45%-1.28M
---37.5K
----
----
----
----
----
----
-Change in payables and accrued expense
216.88%2.27M
-183.16%-1.94M
616.02%2.34M
1,548.98%531.65K
--468.04K
884.71%326.56K
---36.69K
---41.62K
-Change in other current assets
-3.60%189.51K
--196.58K
----
----
----
----
----
----
-Change in other current liabilities
57.53%-323.71K
---762.15K
----
----
----
----
----
----
-Change in other working capital
----
-94.30%-3.84M
0.00%-1.98M
0.00%-494.67K
---494.66K
2.56%-1.98M
---494.67K
---2.03M
Cash from discontinued investing activities
Operating cash flow
31.04%-10.54M
-174.01%-15.29M
-62.62%-5.58M
-67.45%-2.55M
---1.09M
49.00%-3.43M
---1.52M
---6.73M
Investing cash flow
Cash flow from continuing investing activities
32.69%-208.79K
-116.58%-310.2K
30.13%-143.22K
1.87%-52.04K
-30.27K
90.67%-204.99K
-53.03K
-2.2M
Net PPE purchase and sale
40.58%-110.35K
-827.03%-185.71K
42.60%-20.03K
-80.48%-8.75K
---9.34K
98.28%-34.9K
---4.85K
---2.03M
Net intangibles purchase and sale
20.93%-98.44K
-1.05%-124.49K
27.57%-123.19K
10.15%-43.29K
---20.94K
-0.02%-170.09K
---48.18K
---170.06K
Cash from discontinued investing activities
Investing cash flow
32.69%-208.79K
-116.58%-310.2K
30.13%-143.22K
1.87%-52.04K
---30.27K
90.67%-204.99K
---53.03K
---2.2M
Financing cash flow
Cash flow from continuing financing activities
-54.32%8.52M
185.87%18.65M
90.22%6.53M
2,538.45%2.61M
2.36M
4.78%3.43M
-107.22K
3.27M
Net issuance payments of debt
--0
-141.75%-2.61M
1,607.73%6.26M
2,538.45%2.61M
--2.36M
-406.39%-415.27K
---107.22K
--135.54K
Net common stock issuance
24.24%4.19M
1,081.97%3.37M
-92.69%285.11K
100.76%1
--0
24.24%3.9M
---131
--3.14M
Proceeds from stock option exercised by employees
-72.74%5.13M
--18.81M
--0
----
----
--0
----
----
Net other financing activities
12.64%-793.75K
-4,193.96%-908.6K
60.28%-21.16K
--0
--0
---53.27K
--131
----
Cash from discontinued financing activities
Financing cash flow
-54.32%8.52M
185.87%18.65M
90.22%6.53M
2,538.45%2.61M
--2.36M
4.78%3.43M
---107.22K
--3.27M
Net cash flow
Beginning cash position
206.89%4.81M
109.45%1.57M
-21.80%748.02K
-36.18%1.55M
--287.99K
-85.66%956.5K
--2.43M
--6.67M
Current changes in cash
-173.21%-2.23M
280.92%3.05M
487.67%800.89K
100.93%15.62K
--1.24M
96.35%-206.59K
---1.68M
---5.65M
Effect of exchange rate changes
-158.83%-112.17K
972.22%190.65K
1,040.30%17.78K
150.17%296
--18.76K
96.95%-1.89K
---590
---61.92K
End cash Position
-48.78%2.46M
206.89%4.81M
109.45%1.57M
109.45%1.57M
--1.55M
-21.80%748.02K
--748.02K
--956.5K
Free cash flow
31.32%-10.75M
-173.53%-15.66M
-57.40%-5.72M
-65.11%-2.6M
---1.12M
59.26%-3.64M
---1.57M
---8.93M
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
--
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 31.04%-10.54M-174.01%-15.29M-62.62%-5.58M-67.45%-2.55M-1.09M49.00%-3.43M-1.52M-6.73M
Net income from continuing operations -349.68%-5.91M91.23%-1.31M-126.00%-14.98M-168.52%-4.52M---7.3M3.83%-6.63M---1.68M---6.89M
Operating gains losses 49.97%-7.97M-475.26%-15.94M224,465.20%4.25M45,841.19%271.05K--3.97M-97.40%1.89K--590--72.69K
Depreciation and amortization -17.75%633.01K-24.92%769.6K-4.66%1.03M-6.78%250.35K--249.31K18.88%1.08M--268.56K--904.47K
Other non cash items -89.40%717.41K96.85%6.77M1,081.49%3.44M2,692.96%1.92M--1.15M14.80%291.03K--68.81K--253.51K
Change In working capital 122.96%1.54M-2,789.09%-6.7M-402.61%-232.08K14.28%-410.55K---270.81K104.23%76.69K---478.92K---1.81M
-Change in receivables 316.24%676.41K47.13%-312.8K-134.22%-591.62K-953.54%-447.53K---244.18K569.96%1.73M--52.43K--258.05K
-Change in prepaid assets -3,300.45%-1.28M---37.5K------------------------
-Change in payables and accrued expense 216.88%2.27M-183.16%-1.94M616.02%2.34M1,548.98%531.65K--468.04K884.71%326.56K---36.69K---41.62K
-Change in other current assets -3.60%189.51K--196.58K------------------------
-Change in other current liabilities 57.53%-323.71K---762.15K------------------------
-Change in other working capital -----94.30%-3.84M0.00%-1.98M0.00%-494.67K---494.66K2.56%-1.98M---494.67K---2.03M
Cash from discontinued investing activities
Operating cash flow 31.04%-10.54M-174.01%-15.29M-62.62%-5.58M-67.45%-2.55M---1.09M49.00%-3.43M---1.52M---6.73M
Investing cash flow
Cash flow from continuing investing activities 32.69%-208.79K-116.58%-310.2K30.13%-143.22K1.87%-52.04K-30.27K90.67%-204.99K-53.03K-2.2M
Net PPE purchase and sale 40.58%-110.35K-827.03%-185.71K42.60%-20.03K-80.48%-8.75K---9.34K98.28%-34.9K---4.85K---2.03M
Net intangibles purchase and sale 20.93%-98.44K-1.05%-124.49K27.57%-123.19K10.15%-43.29K---20.94K-0.02%-170.09K---48.18K---170.06K
Cash from discontinued investing activities
Investing cash flow 32.69%-208.79K-116.58%-310.2K30.13%-143.22K1.87%-52.04K---30.27K90.67%-204.99K---53.03K---2.2M
Financing cash flow
Cash flow from continuing financing activities -54.32%8.52M185.87%18.65M90.22%6.53M2,538.45%2.61M2.36M4.78%3.43M-107.22K3.27M
Net issuance payments of debt --0-141.75%-2.61M1,607.73%6.26M2,538.45%2.61M--2.36M-406.39%-415.27K---107.22K--135.54K
Net common stock issuance 24.24%4.19M1,081.97%3.37M-92.69%285.11K100.76%1--024.24%3.9M---131--3.14M
Proceeds from stock option exercised by employees -72.74%5.13M--18.81M--0----------0--------
Net other financing activities 12.64%-793.75K-4,193.96%-908.6K60.28%-21.16K--0--0---53.27K--131----
Cash from discontinued financing activities
Financing cash flow -54.32%8.52M185.87%18.65M90.22%6.53M2,538.45%2.61M--2.36M4.78%3.43M---107.22K--3.27M
Net cash flow
Beginning cash position 206.89%4.81M109.45%1.57M-21.80%748.02K-36.18%1.55M--287.99K-85.66%956.5K--2.43M--6.67M
Current changes in cash -173.21%-2.23M280.92%3.05M487.67%800.89K100.93%15.62K--1.24M96.35%-206.59K---1.68M---5.65M
Effect of exchange rate changes -158.83%-112.17K972.22%190.65K1,040.30%17.78K150.17%296--18.76K96.95%-1.89K---590---61.92K
End cash Position -48.78%2.46M206.89%4.81M109.45%1.57M109.45%1.57M--1.55M-21.80%748.02K--748.02K--956.5K
Free cash flow 31.32%-10.75M-173.53%-15.66M-57.40%-5.72M-65.11%-2.6M---1.12M59.26%-3.64M---1.57M---8.93M
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBP
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg